Atlas Trials

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

Clinical trial NCT03879512 · COMPLETED

Trial details

NCT number
NCT03879512
Sponsor
Wuerzburg University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Childhood Glioblastoma
Start date
2018-02-07
Primary completion
2024-07-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.